Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
opioid |
| gptkbp:CASNumber |
2784-73-8
|
| gptkbp:detects |
urine of heroin users
|
| gptkbp:hasMolecularFormula |
C19H21NO4
|
| https://www.w3.org/2000/01/rdf-schema#label |
6-MAM
|
| gptkbp:isomerOf |
gptkb:3-monoacetylmorphine
|
| gptkbp:IUPACName |
gptkb:6-monoacetylmorphine
|
| gptkbp:legalStatus |
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK) Schedule I (Canada) |
| gptkbp:metabolite_of |
gptkb:morphine
amphetamine |
| gptkbp:molecularWeight |
327.37 g/mol
|
| gptkbp:otherName |
gptkb:6-monoacetylmorphine
gptkb:6-acetylmorphine |
| gptkbp:parent_compound |
amphetamine
|
| gptkbp:producedBy |
deacetylation of heroin
|
| gptkbp:psychoactive |
euphoria
analgesia |
| gptkbp:PubChem_CID |
CHEMBL1201207
4515032 5362440 |
| gptkbp:riskFactor |
addiction
death overdose respiratory depression |
| gptkbp:routeOfAdministration |
smoking
intravenous intranasal |
| gptkbp:UNII |
6T3D8C1D6D
|
| gptkbp:bfsParent |
gptkb:6-monoacetylmorphine
|
| gptkbp:bfsLayer |
7
|